Thursday, 19 November 2020
8.15 a.m. – 5.15 p.m.
Over 1100 people
English (simultaneous translation)
Here are the winners of the coveted Swiss Technology Award. With innovation, creativity and the latest technology, they are able to move into global markets and continually create new jobs. We would like to take this opportunity to congratulate all the winners for their success.
Poorly healing wounds are a massive burden for patients, health care systems, and the economy. An aging society and the rise of diabetes further aggravate the issue of non-healing wounds. The ETH Zurich spin-off anavo has developed an approach that radically differs from existing solutions by engineering the wound healing capabilities of inorganic hybrid materials. Working with inexpensive materials that can be produced at scale, their approach differs completely from current solutions that are based on complex biological products or processes. Their prototypes do not only stick strongly to tissues and stop bleeding but additionally have antimicrobial, anti-inflammatory, and tissue-regenerative properties.
Bloom Biorenewables Ltd is a Swiss company providing chemical technologies to accelerate the inevitable transition to sustainable materials. Bloom’s vision is to use widely available plants to manufacture petroleum-like products that can be used by the petro-chemical industry. This is possible today thanks to a recently patented method, which prevents undesired degradation of the most underutilized parts of plants (lignin and hemicellulose). This strategy reveals the hidden value of plants and improves profitability of bio-refineries by unlocking higher value markets. Bloom aims at deploying its solution to manufacture sustainable and cost competitive substitutes to petro-derived products in markets such as fuels, fragrances, materials, plastics or textiles.
CompPair Technologies SA brings on the market healable and sustainable composite material solutions to improve circularity. Composite materials are widely used in sports, marine, windmill and transport industries. However, a major limitation with these materials is their sensitivity to damage. Current repair solutions are costly and time consuming; and recycling is still lacking efficiency. CompPair tackles these limitations by bringing innovative preimpregnated textiles. Composite materials that are built with CompPair products have the following new features: ultra-fast and material-free repairing process, life-time extension, lightweight properties, and efficient recycling.
Givaudan is the global leader in the creation of flavours and fragrances. Ambrofix® is one of the most widely used biodegradable fragrance ingredients, which is now produced using a new breakthrough technology. In alignment with Givaudan’s strategy “Committed to growth, with purpose”, the process of making Ambrofix® through sugar route, is considered as the most sustainable to date. It starts with fermenting sustainably sourced sugar cane while maintaining 100% renewable carbon, thus resulting in zero-carbon waste and a 100% naturally derived molecule.
Founded in 2005 as a spin-off from the ETH, HeiQ is a leader in textile innovation, creating some of the most effective, durable and high-performance textile technologies on the market today. HeiQ’s purpose is to improve the lives of billions of people by perfecting an everyday product: Textiles. Combining three areas of expertise – scientific research, specialty materials manufacturing and consumer ingredient branding – HeiQ is the ideal innovation partner to create differentiating and sustainable textile products. With a yearly capacity of 35 000 tons HeiQ manufactures in the USA, Switzerland and Australia, supplying its specialty chemical products in over 60 countries worldwide.
Sepsis is a life-threatening misguided immune response to an infection. Affecting 50 million people per year, it is one of the greatest global health challenges and is responsible for 20% of all deaths due to the lack of effective treatments.
hemotune AG, a medical device spin-off company from ETH Zurich, is developing a disruptive blood purification technology based on nanoengineered magnetic beads. The goal is to restore immune balance in sepsis and improve patients’ outcomes by selectively removing multiple key compounds directly from the blood.
Schindler’s innovative urban mobility solutions enable the shaping of urban landscapes, now and in the future. Already today, Schindler elevators, escalators, and moving walks move more than 1.5 billion people every day. With Schindler’s revolutionary Robotic Installation System for Elevators (Schindler R.I.S.E) the company breaks new ground in elevator installation. Schindler R.I.S.E is an autonomous robot that climbs the elevator shaft and accurately drills holes into the concrete to set the anchor bolts for the elevator fixations, thereby increasing safety, quality and speed on construction sites.
TOLREMO therapeutics AG is a pre-clinical stage biotechnology company pursuing a novel approach to preventing cancer drug resistance and treating aggressive tumors. Founded in 2017 out of ETH Zurich, the company uses a proprietary technology platform to develop small molecule inhibitors that target a tumor’s faulty software; i.e. gene regulatory programs that are aberrantly expressed in cancer cells. Thanks to this innovative therapeutic concept TOLREMO’s drugs have the potential to improve the long-term efficacy of existing cancer therapies and to treat aggressive cancers which cannot be managed with currently available therapies.
Voliro is an ETH Zurich spin-off and Wyss-Zurich-project. The Start-up is developing advanced flying robots to perform Inspection and Maintenance tasks more safely, cost-effectively and faster than traditional methods. With its tiltable rotor system, Voliro expands the abilities of service drones from “fly and see” to “fly, see and touch”. The unique 360° drone design of the platform allows inspection of curved and sloped surfaces. No other flying inspection robot boasts these capabilities. The flying robot can be equipped with a variety of payloads, such as Non-Destructive Testing (NDT) sensors.
Every year, 50 million people suffer from severe skin injuries. Cutiss uses a small biopsy of the patient and producess with the denovo Skin technology a skin substitute, which enables large area skin transplantation with only minimal scarring. This process, engineered after more than 15 years of research in the Tissue Biology Research Unit of the University Children's Hospital Zurich and is supported by the EU Research, Innovation Programme "Horizon 2020" and Wyss Zurich.
The modern building industry faces challenges to reduce its energy consumption and CO2-footprint, while also ensuring fire-protection. FenX develops a new type of non-flammable insulation foam, which emits three times less CO2 during production than competing products. At the end-of-life, the insulation materials can be recycled in the production of new foams.
Sika is the global market and technology leader for adhesives and sealants. With a new and unique adhesive technology called SikaForce Powerflex it’s possible to combine the advantages of both structural and elastic adhesives. The Curing-by-Design technology allows adaptable pot life followed by immediate curing resulting in drastic production cycle time reduction.